SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Li, QQ; Nie, JH; Wu, JJ; Zhang, L; Ding, RX; Wang, HX; Zhang, Y; Li, T; Liu, S; Zhang, MY; Zhao, CY; Liu, H; Nie, LL; Qin, HY; Wang, M; Lu, Q; Li, XY; Liu, JK; Liang, HY; Shi, Y; Shen, YL; Xie, LZ; Zhang, LQ; Qu, XW; Xu, WB; Huang, WJ; Wang, YC
Huang, WJ; Wang, YC (corresponding author), Natl Inst Food & Drug Control NIFDC, Inst Biol Prod Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, 31 Huatuo St, Beijing 102629, Peoples R China.; Huang, WJ; Wang, YC (corresponding author), WHO, Collaborating Ctr Standardizat & Evaluat Biol, 31 Huatuo St, Beijing 102629, Peoples R China.; Qu, XW (corresponding author), Univ South China, Peoples Hosp Chenzhou 1, Translat Med Inst, Chenzhou 423000, Peoples R China.; Xu, WB (corresponding author
CELL, 2021; 184 (9): 2362
